Getting into the colon: Approaches to target colorectal cancer

Expert Opinion on Drug Delivery

Volumn 11, Issue 9, 2014, Pages 1343-1350

  Patel, Mayur M ^a  

^a NIRMA UNIVERSITY   (India)

Author keywords

Anti cancer agent; Chemotherapy; Colon cancer; Colon targeting; Particulate drug delivery; Receptor mediated transport

Indexed keywords

ANTINEOPLASTIC AGENT;

COLON FLORA; COLORECTAL CANCER; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SAFETY; GASTROINTESTINAL TRACT; HUMAN; REVIEW; STOMACH PH;

ANTI-CANCER AGENT; CHEMOTHERAPY; COLON CANCER; COLON TARGETING; PARTICULATE DRUG DELIVERY; RECEPTOR MEDIATED TRANSPORT;

ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; COLORECTAL NEOPLASMS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS;

EID: 84906318006     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2014.927440     Document Type: Review

References (31)

1. Patel M, Shah T, Amin A. Therapeutic opportunities in colon specific drug delivery systems. Crit Rev Ther Drug Carrier Syst 2007;24:147-202
2. Patel M, Amin A. Recent trends in microbially and/or enzymatically driven colon-specific drug delivery systems. Crit Rev Ther Drug Carrier Syst 2011;28:489-552
3. Patel MM, Amin AF. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer. Drug Deliv 2011;18:281-93
4. American Cancer Society. Available from: Www.cancer.org/cancer/ colonandrectumcancer/detailedguide/ colorectal-cancer-key-statistics [Last accessed on 27 March 2014
5. Elyagoby A, Layas N, Wong TW. Colon-specific delivery of 5-fluorouracil from zinc pectinate pellets through in situ intracapsular ethylcellulose-pectin plug formation. J Pharm Sci 2013;102:604-16
6. Mohandas KM. Colorectal cancer in India: Controversies, enigmas and primary prevention. Indian J Gastroenterol 2011;30:3-6
7. Kelloff GJ, Schilsky RL, Alberts DS, et al. Colorectal adenomas: A prototype for the use of surrogate end points in the development of cancer prevention Drugs. Clin Cancer Res 2004;10:3908-18
8. Levine JS, Ahnen DJ. Clinical practice. Adenomatous polyps of the colon. N Engl J Med 2006;355:2551-7
9. Bond JH. Polyp guideline: Diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 2000;95:3053-63
10. Schatzkin A, Freedman LS, Dawsey SM, Lanza E. Interpreting precursor studies: What polyp trials tell us about largebowel cancer. J Natl Cancer Inst 1994;86:1053-7
11. Stewart SL, Wike JM, Kato I, et al. A population-based study of colorectal cancer histology in the United States, 1998-2001. Cancer 2006;107(5 Suppl):1128-41
12. Colorectal cancer. Available from: Www. cancer.org/acs/groups/content/ epidemiologysurveilance/documents/ document/acspc-028323.pdf [Last accessed 27 March 2014
13. Krishnaiah YS, Khan MA. Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer. Pharm Dev Technol 2012;17:521-40
14. Patel MM. Drug delivery: Oral colon-specific. In: Swarbrick J, editor. Encyclopedia of pharmaceutical science and technology. 4th edition. Taylor &Francis Group, LLC, UK; 2014. p. 1091-121
15. Patel MM, Amin AF. Process, optimization and characterization of mebeverine hydrochloride loaded guar gum microspheres for irritable bowel syndrome. Carbohydr Polym 2011;86:536-45
16. Patel MM. Cutting-edge technologies in colon-Targeted drug delivery systems. Expert Opin Drug Deliv 2011;8:1247-58
17. Jain A, Jain SK, Ganesh N, et al. Design and development of ligand-Appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer. Nanomedicine 2010;6:179-90
18. Zhang L, Zhu W, Yang C, et al. A novel folate-modified self-microemulsifying drug delivery system of curcumin for colon targeting. Int J Nanomedicine 2012;7:151-62
19. Ashwanikumar N, Kumar NA, Nair SA, Kumar GV. Methacrylic-based nanogels for the pH-sensitive delivery of 5-fluorouracil in the colon. Int J Nanomedicine 2012;7:5769-79
20. Ghorab DM, Amin MM, Khowessah OM, Tadros MI. Colon-Targeted celecoxib-loaded Eudragit- S100-coated poly-caprolactone microparticles: Preparation, characterization and in vivo evaluation in rats. Drug Deliv 2011;18:523-35
21. Kulthe SS, Bahekar JK, Godhani CC, et al. Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: An industrially feasible approach. Drug Dev Ind Pharm 2013;39:138-45
22. Ahmad MZ, Akhter S, Anwar M, Ahmad FJ. Assam Bora rice starch based biocompatible mucoadhesive microsphere for targeted delivery of 5-fluorouracil in colorectal cancer. Mol Pharm 2012;9:2986-94
23. Smitha KT, Anitha A, Furuike T, et al. In vitro evaluation of paclitaxel loaded amorphous chitin nanoparticles for colon cancer drug delivery. Colloids Surf B Biointerfaces 2013;104:245-53
24. Sharma M, Malik R, Verma A, et al. Folic acid conjugated guar gum nanoparticles for targeting methotrexate to colon cancer. J Biomed Nanotechnol 2013;9:96-106
25. Srivastava R, Kumar D, Pathak K. Colonic luminal surface retention of meloxicam microsponges delivered by erosion based colon-Targeted matrix tablet. Int J Pharm 2012;427:153-62
26. Yassin AE, Alsarra IA, Alanazi FK, et al. New targeted-colon Delivery system: In vitro and in vivo evaluation using X-ray imaging. J Drug Target 2010;18:59-66
27. Sharma R, Rawal RK, Malhotra M, et al. Design, synthesis and ex-vivo release studies of colon-specific polyphosphazene-Anticancer drug conjugates. Bioorg Med Chem 2014;22:1104-14
28. Dev RK, Bali V, Pathak K. Novel microbially triggered colon specific delivery system of 5-Fluorouracil: Statistical optimization, in vitro, in vivo, cytotoxic and stability assessment. Int J Pharm 2011;411:142-51
29. Thakral NK, Ray AR, Bar-Shalom D, et al. The quest for targeted delivery in colon cancer: Mucoadhesive valdecoxib microspheres. Int J Nanomedicine 2011;6:1057-68
30. Zhang L, Cao F, Ding B, et al. Eudragit S100 coated calcium pectinate microspheres of curcumin for colon targeting. J Microencapsul 2011;28:659-67
31. Deol PK, Kaur IP. Improving the therapeutic efficiency of ginger extract for treatment of colon cancer using a suitably designed multiparticulate system. J Drug Target 2013;21:855-65.